Natural history of hepatitis C in HIV-negative patients with congenital coagulation disorders

Journal of Hepatology

Volumn 31, Issue 3, 1999, Pages 400-406

  Meijer, Karina ^a   Haagsma, Elizabeth B ^a   Kok, Theodorus ^a   Schirm, Jurjen ^b   Smid, W Martin ^a   Meer, Jan van der ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Public Health Service of Groningen   (Netherlands)

Author keywords

Chronic hepatitis C; Cirrhosis; Hemophilia; Ultrasonography

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; DISEASE COURSE; ECHOGRAPHY; FEMALE; HEMOPHILIA; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; PROGNOSIS; SPLENOMEGALY; TREATMENT PLANNING; VIRUS LOAD;

EID: 0033198378     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80029-4     Document Type: Article

References (38)

1. Alter MJ. The epidemiology of hepatitis C in the west. Semin Liver Dis. 15:1995;5-14.
2. Mauser-Bunschoten EP, Bresters D, Van Drimmelen AAJ, Roosendaal G, Cuypers HTM, Reesing HW, et al. Hepatitis C infection and viremia in Dutch hemophilia patients. J Med Virol. 45:1995;241-246.
3. Darby SC, Ewart DW, Giangrande PLF, Spooner RJD, Rizza CR, Dusheiko GM, et al. for the UK Haemophilia Centre Directors' Organisation. Mortality from liver cancer and liver disease in haemophilic men and boys given blood products contaminated with hepatitis C. Lancet. 350:1997;1425-1431.
4. Triemstra M, Rosendaal FR, Smit C, Van der Ploeg HM, Briët E. Mortality in patients with hemophilia, changes in a Dutch population from 1986 to 1992 and 1973 to 1986. Ann Intern Med. 123:1995;823-827.
5. Makris M, Preston FE, Rosendaal FR, Underwood JCE, Rice KM, Triger DR. The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol. 94:1996;746-752.
6. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C. The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol. 87:1994;555-561.
7. Hanley JP, Jarvis LM, Andrews J, Dennis R, Hayes PC, Piris J, et al. Interferon treatment for chronic hepatitis C infection in hemophiliacs - influence of virus load, genotype, and liver pathology on response. Blood. 87:1996;1704-1709.
8. Telfer P, Devereux H, Colvin B, Hayden S, Dusheiko G, Lee C. Alpha interferon for hepatitis C virus infection in haemophilic patients. Haemophilia. 1:1995;54-58.
9. Rumi MG, Santagostino E, Morfini M, Gringeri A, Tagariello G, Chistolini A, et al. the Hepatitis Study Group of the Association of Italian Hemophilia Centers . A multicenter controlled, randomized, open trial of interferon α2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Blood. 89:1997;3529-3533.
10. Wadelius C, Lindstedt M, Pigg M, Egberg N, Pettersson U, Anvret M. Hemophilia B in a 46,XX female probably caused by non-random X inactivation. Clin Genet. 43:1993;1-4.
11. Fletcher ML, Trowell JM, Craske J, Pavier K, Rizza CR. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J. 287:1983;1754-1757.
12. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, et al. Haemochromatosis and HLA-H. Nature Genetics. 14:1996;249-251.
13. Smith DB, Mellor J, Jarvis LM, Davidson F, Kolberg J, Urdea M, et al. The International HCV Collaborative Study Group . Variation of the hepatitis C virus 5′ non-coding region: Implications for secondary structure, virus detection and typing. J Gen Virol. 76:1995;1749-1761.
14. Gaiani S, Gramantieri L, Venturoli N, Piscaglia F, Siringo S, D'Errico A, et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol. 27:1997;979-985.
15. Zwiebel WJ. Sonographic diagnosis of diffuse liver disease. Semin Ultrasound. 16:1995;8-15.
16. Zoli M, Cordiani MR, Marchesini G, Abbati S, Bianchi G, Pisi E. Ultrasonographic follow-up of liver cirrhosis. J Clin Ultrasound. 18:1990;91-96.
17. Borzio M, Borzio F, Croce A, Sala M, Salmi A, Leandro G, et al. Ultrasonography-detected macroregenerative nodules in cirrhosis: a prospective study. Gastroenterology. 112:1997;1617-1623.
18. Celle G, Savarino V, Picciotto A, Magnolia MR, Scalabrini P, Dodero M. Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques. Dig Dis Sci. 33:1988;467-471.
19. Debongnie JC, Pauls C, Fievez M, Wibin E. Prospective evaluation of the diagnostic accuracy of liver ultrasonography. Gut. 22:1981;130-135.
20. Cioni G, Tincani E, D'Alimonte P, Cristani A, Ventura P, Abbati G, et al. Relevance of reduced portal flow velocity, low platelet count and enlarged spleen diameter in the non-invasive diagnosis of compensated liver cirrhosis. Eur J Med. 2:1993;408-410.
21. Di Lelio A, Cestari C, Lomazzi A, Beretta L. Cirrhosis: diagnosis with sonographic study of the liver surface. Radiology. 172:1989;389-392.
22. Telfer P. Liver biopsy for haemophilic patients with chronic HCV infection. Br J Haematol. 99:1997;239-240.
23. Lee CA. Investigations of chronic hepatitis C infection in individuals with haemophilia. Br J Haematol. 96:1997;425-426.
24. McAfee JH, Keeffe EB, Lee RG, Rösch J. Transjugular liver biopsy. Hepatology. 15:1992;726-732.
25. Hanley JP, Jarvis LM, Andrews J, Dennis R, Lee R, Simmonds P, et al. Investigation of chronic hepatitis C infection in individuals with haemophilia: assessment of invasive and non-invasive methods. Br J Haematol. 94:1996;159-165.
26. Freeman MP, Vick CW, Taylor KJW, Carithers RL, Brewer WH. Regenerating nodules in cirrhosis: sonographic appearance with anatomic correlation. Am J Roentgenol. 146:1986;533-536.
27. Gusberg RJ, Peterec SM, Sumpio BE, Meier GH. Splenomegaly and variceal bleeding - hemodynamic basis and treatment implications. Hepatol-Gastroenterol. 41:1994;573-577.
28. Schalm SW. The diagnosis of cirrhosis: Clinical relevance and methodology. [editorial] J Hepatol. 27:1997;1118-1119.
29. Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, et al. Long-term follow-up of non-A, non-B (type C) posttransfusion hepatitis. J Hepatol. 16:1992;273-281.
30. Esteban JI, López-Talavera JC, Genescà J, Madoz P, Viladomiu L, Muňiz E, et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med. 115:1991;443-449.
31. Petrelli E, Manzin A, Paolucci S, Cioppi A, Brugia M, Muretto P, et al. Chronic liver disease and active hepatitis C virus infection in patients with antibodies to this virus. J Clin Pathol. 47:1994;148-151.
32. Soto B, Sánchez-Quijano A, Rodrigo L, Del Olmo JA, García-Bengoechea M, Hernández- Quero J, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol. 26:1997;1-5.
33. Pol S, Fontaine H, Carnot F, Zylberberg H, Berthelot P, Bréchot C, et al. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients. J Hepatol. 29:1998;12-19.
34. Poynard T, Bedossa P, Opolon P, for the OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups . Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 349:1997;825-832.
35. Eyster ME, Diamondstone LS, Lien JM, Ehmann C, Quan S, Goedert JJ. for the Multicenter Hemophilia Cohort Study. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. J Acq Immune Defic Syndr. 6:1993;602-610.
36. Allersma DP, Smid WM, Briët E. Abnormal immune parameters in HIV seronegative haemophilic patients. Haemophilia. 2:1996;65-72.
37. Pessione F, Degos F, Marcellin P, Duchatelle V, Njapoum C, Martinot-Peignoux M, et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology. 27:1998;1717-1722.
38. Ostapowicz G, Watson KJR, Locarnini SA, Desmond PV. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology. 27:1998;1730-1735.